FDA 510(k) Clearance Granted to Assurance Alar Sensor for Anesthesia

Assurance Biosense was granted FDA 510(k) clearance to market its Alar Sensor, an anesthesia device used for monitoring oxygen saturation in arterial hemoglobin and pulse rate.

Advertisement

The device allows for continuous non-invasive monitoring and compatibility with other large monitoring devices. Assurance developed the Alar Sensor based on clinical data that showed central monitoring of pulse oximetry to be an improvement over peripheral sites, such as finger tips, according to the release.

More Articles on Anesthesia:
Anesthesiologist Dr. Brian Brown Rushed to Aid Boston Marathon Bombing Victims
MedWatch Releases Changes for 53 Drug Safety Labels
Teleflex Grants Anesthesia Supply Distribution Rights to HealthTrust

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Anesthesia

  • As the shortage of physician anesthesiologists across the U.S. becomes more severe, certified-registered nurse anesthetists have emerged as an essential…

  • As of April 6, 2026, CRNAs’ average annual salary is $276,434, according to salary transparency platform Marit Health’s compilation of…

Advertisement

Comments are closed.